Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Product › Details

quantum cascade laser (QCL) technology

Products Next higher product group infrared microscope
Period Status 2018-02-22 existent
Organisation Organisation IRM² Infrarot Mikroskopie und Messtechnik GmbH
  Group Bruker (Group)
     

Bruker Corporation. (2/22/18). "Press Release: Bruker Acquires High-Speed QCL Infrared Microscopy Company IRM²". Ettlingen.

Bruker today announced that it has acquired IRM², a developer of high-speed infrared (IR) imaging microscopes based on quantum cascade laser (QCL) technology. Innovative, fast QCL microscopy expands Bruker's technology portfolio and market opportunities for infrared microscopy, with applications in biological tissue analysis and materials science, and future potential in tissue diagnostics. Financial details of the transaction were not disclosed.



QCL-based IR microscope


QCL is a novel technology in infrared and Raman microscopy, with key customers at academic and government research institutions, as well as in pharmaceutical and biotechnology companies. The IRM² QCL platform provides direct infrared imaging with detector arrays at very high speed. A proprietary coherence reduction technique delivers unprecedented image quality, so that the composition of large sample areas can be studied much more rapidly and at high lateral resolution.

Urban Fäh, President of Bruker Optics, stated: "Novel QCL technology can offer major speed advantages for infrared and Raman microscopy of large sampling areas, with great promise for the selective screening of biological tissues. The QCL microscopy technology expands our product portfolio, and we welcome the addition of the talented IRM² team, which provides valuable new expertise."

Dr. Niels Kröger-Lui, founder and CEO of IRM², commented: "The IRM2 team is proud to become part of Bruker. This is the next step in our vision of transferring the results of our academic research to industrial products that serve customers globally. We believe that Bruker provides the environment for IRM² to integrate our know-how and technology into innovative and competitive QCL microscopy and spectroscopy solutions."


About Bruker Corporation (NASDAQ: BRKR)

For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com.

Investor Contact:


Media Contact for Bruker Optics:

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
T: +1 (978) 663-3660, ext. 1479
E: miroslava.minkova@bruker.com

Michael Mueller
Marketing Manager
Bruker Optics
T: +49 (7243) 504-2652
E: michael.mueller@bruker.com

   
Record changed: 2023-07-10

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for microscope_o


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top